Selective ET(A) receptor antagonism with ABT-627 attenuates all renal effects of endothelin in humans. [electronic resource]
Producer: 20000908Description: 1498-1504 p. digitalISSN:- 1046-6673
- Adult
- Atrasentan
- Calcium Channel Blockers -- pharmacology
- Cross-Over Studies
- Diuresis -- drug effects
- Dose-Response Relationship, Drug
- Double-Blind Method
- Endothelin Receptor Antagonists
- Endothelin-1 -- pharmacology
- Female
- Hemodynamics -- drug effects
- Humans
- Kidney -- drug effects
- Male
- Nifedipine -- pharmacology
- Pyrrolidines -- administration & dosage
- Receptor, Endothelin A
- Renal Circulation -- drug effects
- Vasoconstrictor Agents -- pharmacology
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.